-
Three Small Cap Biotech Stocks Added to Citi's Most Preferred List (ATRA) (NVAX) (PBYI)
-
Citi Starts Supernus Pharmaceuticals (SUPN) at Neutral
-
Supernus Pharmaceuticals (SUPN) IPO Traders Slightly Higher After Rocky Pricing
-
CNS Treatment Developer Supernus Pharma (SUPN) Lowers IPO Expectations
-
Supernus (SUPN) Files $100 Million IPO

